Drug intelligence / Profile preview

AKVANO vehicle formulation 1

Development stage: Unknown
Lead developer: Lipidor
Modality: Small Molecules
Administration: Topical

Overview

AKVANO vehicle formulation 1 is a water-free, sprayable vehicle control developed by Lipidor AB, utilizing their proprietary AKVANO technology. This lipid-based delivery system is designed for topical application, where selected lipids are dissolved in a volatile solvent that evaporates rapidly upon contact with the skin, leaving a thin, non-greasy lipid film. As a vehicle formulation, it contains the components of the AKVANO platform but lacks an active pharmaceutical ingredient (API). It was specifically utilized as a placebo comparator in Phase I clinical trials to evaluate the antipsoriatic efficacy and safety of calcipotriol-loaded AKVANO formulations in patients with psoriasis vulgaris.

Brand names: AKVANO
Other names: AKVANO vehicle 1

Beyond the preview

Go deeper on AKVANO vehicle formulation 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AKVANO vehicle formulation 1.

Explore the full profile